If you've searched "compounded semaglutide cost" recently, you've probably noticed something strange. The answers are wildly inconsistent. One site says \$99 a month. Another says \$299. A third says \$499. Even within a single telehealth provider, the "starting price" on the landing page often turns out to be very different from what shows up at checkout.

There's a reason for that. The compounded GLP-1 market is fragmented, fast-moving, and structured in a way that makes price comparisons harder than they should be. And it's made even more confusing by the fact that branded Wegovy's cash-pay price has dropped significantly in the last 12 months, compressing the gap between the expensive brand-name option and the affordable compounded alternative that used to define this category.

Here's an honest, detailed breakdown of what compounded semaglutide actually costs in 2026, what drives the differences between providers, and how to figure out whether a given program is a good deal or not.

The short answer

In 2026, compounded semaglutide from a legitimate telehealth provider typically costs \$149 to \$299 per month as an all-in price. Most of the mid-market, the programs that include a licensed provider consultation, B12, shipping, and ongoing support, sits in the \$179 to \$249 band. Programs advertising below \$149 often have hidden fees, variable pricing that escalates with your dose, or reduced levels of medical oversight. Programs above \$299 typically bundle in more extensive coaching or premium services.

For context, brand-name Wegovy now costs roughly \$349 per month through Novo Nordisk's direct cash-pay program, and \$1,349 per month at traditional pharmacy list price. Compounded remains meaningfully cheaper than brand-name injectables in most cases, but the gap is narrower than it was two years ago.

The 2026 pricing landscape

This is what the market looks like as of April 2026. Prices are publicly listed starting rates and may change.

Brand-name Wegovy, list price: approximately \$1,349/month, medication only. Brand-name Wegovy, NovoCare cash-pay: approximately \$349/month, medication only. Oral Wegovy (pill), cash-pay: \$149 to \$299/month depending on dose. Brand-name Zepbound, LillyDirect vial program: \$299 to \$449/month depending on dose. Brand-name with commercial insurance plus savings card: \$25 to \$100/month if covered. Compounded semaglutide, budget tier: \$99 to \$149/month. Provider support varies. Compounded semaglutide, mid tier (most common): \$179 to \$249/month. Includes medication, provider, shipping. Compounded semaglutide, premium tier: \$249 to \$349/month. Adds coaching or extended support.

The single biggest takeaway: "compounded" doesn't mean one thing. There's a wide range of providers, pricing structures, and levels of care quality. What you pay is partly the medication and largely the business model behind it.

What actually goes into the price

When you pay for compounded semaglutide through a telehealth provider, you're paying for four distinct things bundled into one monthly fee.

The medication itself. The semaglutide is compounded by a licensed 503A pharmacy based on a valid, patient-specific prescription. Raw material cost, preparation cost, sterility testing, and packaging are part of this. Pharmacies with stricter quality programs (third-party potency testing, PCAB accreditation) typically cost more at the wholesale level than bare-bones facilities.

The provider consultation and ongoing medical oversight. A licensed U.S. provider has to review your health history, determine whether you're an appropriate candidate, write the prescription, and remain available for dose adjustments, side effect management, and clinical questions. This is the biggest variable in pricing structure. Some programs include unlimited provider access; others charge separately for each message or follow-up.

Shipping and fulfillment. Semaglutide requires cold-chain shipping. Temperature-controlled packaging, overnight or two-day delivery, and signature-on-delivery are all costs that get baked into the price. Some programs list shipping as a separate line item; others include it.

The platform itself: technology, support, compliance. HIPAA-compliant patient portals, intake software, support staff, state licensing administration, LegitScript certification fees, and other operational costs all factor in.

When a program advertises a rate dramatically below the mid-market average, one or more of those four components has been stripped down. That's not inherently bad, but it's worth understanding what you're giving up.

The hidden fees most cheap programs don't advertise

One of the most common complaints among GLP-1 telehealth patients is that the advertised price isn't what they ended up paying. A 2025 Consumer Reports survey of GLP-1 telehealth patients found that roughly one-third hit unexpected charges during treatment, charges that weren't disclosed before they signed up.

The fees to watch for:

Monthly membership or platform fees. Some programs advertise "medication from \$99" but add \$39 to \$149/month in separate membership fees. The real monthly cost is the sum of both.

Consultation or intake fees. A one-time \$75 to \$150 intake fee charged on top of the first month. Some programs refund this if you're ineligible; others don't.

Per-dose upcharges. This is the big one. Many compounded providers price by dose, so your price climbs as you titrate up from the starting dose. A program that starts at \$169 at 0.25 mg can reach \$399 to \$499 at maintenance doses. Your first month looks like a bargain; your sixth month looks like brand-name.

Lab fees. Some programs require bloodwork and charge separately for the order, the draw, and the lab review.

Cancellation fees. Prepaid multi-month bundles are often non-refundable once the prescription is written. If you need to stop treatment for any reason, the money is gone.

Rush shipping surcharges. If your medication is delayed or you need a faster turnaround, some programs charge \$25 to \$75 extra for expedited delivery.

None of these fees are scandalous on their own. But a program that bundles everything into one flat rate with no surprises is structurally easier to budget for than one where each component is billed separately.

Why "any dose, same price" matters more than most people realize

The single most important number in comparing compounded programs is how they handle dose escalation.

Semaglutide is designed to start at a low dose (0.25 mg weekly) and escalate every four weeks until you reach your maintenance dose (typically 1.7 mg or 2.4 mg). That escalation takes about five months. Under dose-based pricing, your cost typically rises at each step, sometimes modestly, sometimes dramatically.

Here's what that looks like in practice. Imagine two programs, both advertising a starting price of "from \$169/month."

Program A (any dose, same price): You pay \$199/month throughout treatment. Twelve-month total: \$2,388.

Program B (dose-based pricing): You pay \$169 at 0.25 mg, \$219 at 0.5 mg, \$279 at 1 mg, \$349 at 1.7 mg, and \$449 at 2.4 mg. Twelve-month total: \$4,236 (assuming standard escalation to maintenance dose).

The landing page made Program B look cheaper. The twelve-month reality is that it costs almost twice as much.

This matters because, for most patients, the maintenance dose is where the actual weight loss happens. The first few months of low-dose escalation produce modest results. The real clinical benefit is during month 6 through month 18, at full dose, which is exactly when dose-based pricing programs become most expensive.

When comparing programs, always ask: "What will I pay at the maintenance dose?" That's the number that defines your real twelve-month cost.

Is compounded worth it now that branded prices have dropped?

This is a fair question in 2026, and the honest answer is: it depends on your situation.

The gap has narrowed. Brand-name Wegovy through NovoCare Direct is now \$349/month for cash-pay patients. If you have commercial insurance with some form of GLP-1 coverage, branded options can drop to as low as \$25/month with a manufacturer savings card. For those patients, the cost argument for compounded is weaker than it was in 2023 or 2024.

However, compounded semaglutide still makes sense for several types of patients. Cash-pay patients with no insurance coverage, where compounded at \$179 to \$249/month remains meaningfully cheaper than brand-name cash-pay at \$349/month. Patients who prefer the all-inclusive telehealth model (provider, medication, shipping, support all bundled) over managing a pharmacy relationship, a savings card, and a prescriber separately. Patients whose insurance excludes weight-loss medications entirely (still roughly 70 to 75% of commercial plans). Patients whose preferred dose isn't available consistently in brand-name form. Patients who want vitamins like B12 included in their compound for added energy support during weight loss, something brand-name products don't offer.

If branded Wegovy is fully covered by your insurance, it's usually the right financial choice. Everyone else is doing the math on cash-pay options, and compounded typically still wins that math, especially with a flat-price, any-dose program.

FSA and HSA: can you use pre-tax dollars?

Prescription semaglutide, both brand-name and compounded, is generally eligible for reimbursement through Flexible Spending Accounts (FSAs), Health Savings Accounts (HSAs), and Health Reimbursement Arrangements (HRAs), because it's a medically necessary prescription from a licensed provider for a qualifying health condition.

The mechanics vary by provider. Some telehealth platforms accept FSA and HSA cards directly at checkout. Others don't, but patients can still submit receipts to their plan administrator for reimbursement after paying with a standard credit or debit card.

CLYR is currently cash-pay only (Stripe-processed payments including Apple Pay, major cards, Cash App, Google Pay, and BNPL options like Klarna, Affirm, and Afterpay). Patients with FSAs, HSAs, or employer HRAs can pay with their preferred card, then submit the itemized receipt for reimbursement through their account. The medication and provider consultation are both qualifying medical expenses under IRS rules (IRC Section 213(d)).

We generate detailed receipts with the information most plan administrators require: provider name, treatment description, diagnosis code, and total cost.

Questions to ask any GLP-1 telehealth provider before you enroll

Before signing up for any program, ask the following. Any legitimate provider should be able to answer all five in under a minute.

1. "What will I pay at the maintenance dose?" If the answer is meaningfully higher than the starting price, the program uses dose-based pricing. Price it out fully before enrolling. 2. "Is there a separate membership, platform, or consultation fee?" The advertised price should be the whole price. 3. "If I'm not eligible after intake, do I get a full refund?" Any provider that charges for an ineligible prescription isn't serving your interests. 4. "What pharmacy prepares the medication, and are they 503A licensed and PCAB accredited?" This is a quality signal. Legitimate programs will tell you their pharmacy partners. 5. "Are you LegitScript certified?" LegitScript is the most rigorous third-party certification for healthcare telehealth. Most compounded GLP-1 providers aren't certified. Being certified is a meaningful trust signal.

The CLYR approach: ceiling pricing

CLYR's pricing is designed to solve for the two things most frustrating about the compounded GLP-1 market: hidden fees and dose-based upcharges.

Semaglutide plus B12: \$225/month on a month-to-month plan. This is the most you'll ever pay. Commit to a 3-month plan and the price drops to \$179/month. Commit to a 6-month plan and the price drops to \$149/month.

Any dose, same price. From 0.25 mg through your full maintenance dose, the price doesn't change.

Provider consultation, ongoing care, B12, and priority shipping are all included. No membership fees. No lab fees. No consultation fees. No rush charges.

If our licensed provider determines you're not eligible, you receive a full refund. You take no financial risk to start.

We call it "ceiling pricing" because the advertised price is the ceiling, not the floor. Most of the market works the opposite way: a low starting price that climbs. Ours starts at the ceiling and only goes down as you commit longer.

We also offer compounded tirzepatide with B12 at \$320/month, \$259/month (3-month), and \$225/month (6-month), same pricing structure, same any-dose guarantee.

Frequently asked questions

What's the cheapest legitimate compounded semaglutide in 2026? Legitimate compounded semaglutide programs generally start at \$149/month for programs with dose-based pricing on their starter doses, or \$99 to \$199/month for flat-rate programs on multi-month commitments. Below \$99 is rare among providers with full provider oversight and LegitScript certification.

Why does compounded semaglutide cost less than Wegovy? Compounded medications are prepared by 503A compounding pharmacies based on individual prescriptions. They don't carry the same marketing, R&D amortization, or branded distribution costs as FDA-approved commercial drugs. Compounded medications are not FDA-approved as finished products.

Are there hidden fees I should look out for? Yes. The most common are monthly membership fees, dose-based pricing that escalates as you titrate up, one-time intake fees, lab fees, and non-refundable multi-month commitments. Always ask for the total cost at maintenance dose before enrolling.

Can I use my FSA or HSA to pay for compounded semaglutide? In most cases, yes. Prescription GLP-1 medications are generally eligible medical expenses under IRC Section 213(d). Some providers accept FSA/HSA cards directly; others require you to pay and submit receipts for reimbursement. Check with your plan administrator to confirm.

Will the price change when my dose increases? It depends on the provider. Some charge the same price regardless of dose (flat pricing). Others charge more as your dose increases (dose-based pricing). The difference can be \$1,000 or more over a year of treatment. Always ask what you'll pay at maintenance dose before enrolling.

Is brand-name Wegovy actually affordable now? For some patients, yes. Through Novo Nordisk's NovoCare direct-pay program, cash-pay Wegovy is approximately \$349/month for maintenance doses. With commercial insurance plus a manufacturer savings card, it can drop to as low as \$25/month. Whether it's affordable for you depends on your insurance status.

Does compounded semaglutide work as well as Wegovy? Compounded semaglutide contains semaglutide as its active ingredient. However, compounded versions are not FDA-approved as finished products and are prepared in individual batches rather than through standardized manufacturing. Individual patient outcomes vary with any medication. Your licensed provider can discuss which option best fits your specific situation.

The Bottom Line

The compounded GLP-1 market in 2026 is more varied than ever. Real legitimate compounded semaglutide costs \$149 to \$299 per month all-in. Below that, watch for hidden fees and dose-based upcharges that double your real twelve-month cost. Above that, you're paying for premium services that may or may not be worth it. Branded options have come down, and for patients with insurance coverage, they're now often the right financial choice.

If you're considering compounded semaglutide, CLYR Health offers transparent flat pricing starting at \$149 per month on a 6-month plan, with no hidden fees, any-dose guarantee, and a full refund if you're not a candidate. Start your assessment at /intake.html.